231 related articles for article (PubMed ID: 10551756)
1. Managing intractable pain with an intrathecal catheter and injection port: technique and guidelines.
Meenan D; Lagares-Garcia JA; Kurek S; Craig D; Green J; Fritz W
Am Surg; 1999 Nov; 65(11):1054-60. PubMed ID: 10551756
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal narcotic infusion pumps for intractable pain of chronic pancreatitis: a pilot series.
Kongkam P; Wagner DL; Sherman S; Fogel EL; Whittaker SC; Watkins JL; McHenry L; Lehman GA
Am J Gastroenterol; 2009 May; 104(5):1249-55. PubMed ID: 19367269
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain.
Deer TR; Smith HS; Burton AW; Pope JE; Doleys DM; Levy RM; Staats PS; Wallace MS; Webster LR; Rauck RL; Cousins M;
Pain Physician; 2011; 14(3):E283-312. PubMed ID: 21587338
[TBL] [Abstract][Full Text] [Related]
4. [Management of intractable cancer pain: from intrathecal morphine to cell allograft].
Lazorthes Y; Sallerin B; Verdie JC; Sol JC; Duplan H; Tkaczuk J; Tafani M; Bastide R; Bes JC
Neurochirurgie; 2000 Nov; 46(5):454-65. PubMed ID: 11084478
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal catheter-syringe adaptor for short-term intrathecal analgesia with an externalized pump: a case report.
Wilkes D; Cook M; Solanki D
Pain Physician; 2010; 13(2):151-6. PubMed ID: 20309381
[TBL] [Abstract][Full Text] [Related]
6. [Continuous intrathecal opiate therapy with a portable drug pump in cancer pain].
Motsch J; Bleser W; Ismaily AJ; Distler L
Anasth Intensivther Notfallmed; 1988 Oct; 23(5):271-5. PubMed ID: 2907271
[TBL] [Abstract][Full Text] [Related]
7. Intraspinal delivery of opiates by an implantable, programmable pump in patients with chronic, intractable pain of nonmalignant origin.
Kanoff RB
J Am Osteopath Assoc; 1994 Jun; 94(6):487-93. PubMed ID: 8077118
[TBL] [Abstract][Full Text] [Related]
8. Median arcuate ligament syndrome--a novel treatment using an intrathecal morphine pump to relieve intractable visceral pain.
Guttman OT; Rosenblatt MA; Mims T
Pain Pract; 2008; 8(2):133-7. PubMed ID: 18194349
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices.
Stearns L; Boortz-Marx R; Du Pen S; Friehs G; Gordon M; Halyard M; Herbst L; Kiser J
J Support Oncol; 2005; 3(6):399-408. PubMed ID: 16350425
[TBL] [Abstract][Full Text] [Related]
10. Priapism--a rare complication following continuous epidural morphine and bupivacaine infusion.
Ruan X; Couch JP; Shah RV; Liu H; Wang F; Chiravuri S
Pain Physician; 2007 Sep; 10(5):707-11. PubMed ID: 17876369
[TBL] [Abstract][Full Text] [Related]
11. The epidural opioid internalized system.
Miller BJ; Wyant GM
Can J Surg; 1987 Jan; 30(1):42-4. PubMed ID: 3815180
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of continuous intraspinal narcotic analgesia for chronic pain from benign causes.
Yoshida GM; Nelson RW; Capen DA; Nagelberg S; Thomas JC; Rimoldi RL; Haye W
Am J Orthop (Belle Mead NJ); 1996 Oct; 25(10):693-4. PubMed ID: 8922167
[TBL] [Abstract][Full Text] [Related]
13. Management of chronic cancer pain using a computerized ambulatory patient-controlled analgesia pump.
Wagner JC; Souders GD; Coffman LK; Horvath JL
Hosp Pharm; 1989 Aug; 24(8):639-40, 642-4. PubMed ID: 10294360
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and technical complications of long-term continuous intraspinal infusions of opioid and/or bupivacaine in refractory nonmalignant pain: a comparison between the epidural and the intrathecal approach with externalized or implanted catheters and infusion pumps.
Dahm P; Nitescu P; Appelgren L; Curelaru I
Clin J Pain; 1998 Mar; 14(1):4-16. PubMed ID: 9535309
[TBL] [Abstract][Full Text] [Related]
15. A cost utilization analysis of intrathecal therapy for refractory cancer pain: identifying factors associated with cost benefit.
Brogan SE; Winter NB; Abiodun A; Safarpour R
Pain Med; 2013 Apr; 14(4):478-86. PubMed ID: 23461787
[TBL] [Abstract][Full Text] [Related]
16. Improvement in psychosocial outcomes in chronic pain patients receiving intrathecal morphine infusions.
Duse G; Davià G; White PF
Anesth Analg; 2009 Dec; 109(6):1981-6. PubMed ID: 19923529
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal catheters with subcutaneous port systems in patients with severe cancer-related pain managed out of hospital: the risk of infection.
Holmfred A; Vikerfors T; Berggren L; Gupta A
J Pain Symptom Manage; 2006 Jun; 31(6):568-72. PubMed ID: 16793497
[TBL] [Abstract][Full Text] [Related]
18. To replace or not to replace? - Partial coning and a sixth nerve palsy secondary due to displacement of a tunnelled intrathecal catheter for pain control.
Gibbins J; Steeds C; Greenslade GL; Tunstall SR; Patel NK; Stannard CF
Palliat Med; 2008 Jul; 22(5):668-70. PubMed ID: 18612034
[TBL] [Abstract][Full Text] [Related]
19. [Clinical outcome of totally implantable subcutaneous infusion port--comparison with home parenteral nutrition and chemotherapy].
Taniguchi K; Oka K; Tokuyasu N; Naka T; Kondo A; Tsujitani S; Ikeguchi M
Gan To Kagaku Ryoho; 2008 Feb; 35(2):281-5. PubMed ID: 18281766
[TBL] [Abstract][Full Text] [Related]
20. Intractable cancer pain: a new technique for attack in a patient with an implanted intrathecal infusion pump.
Kowal AG; Staats PS
Reg Anesth; 1997; 22(6):584. PubMed ID: 9425980
[No Abstract] [Full Text] [Related]
[Next] [New Search]
